Recurrent Differentiated Thyroid Gland Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Differentiated Thyroid Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) (NCT02973997) | Academic and Community Cancer Research United | 2018-02-07 |
Track Recurrent Differentiated Thyroid Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.